Search
Pulmonx Corp
LUNGAdd to Watchlist
2.800USD
+0.240+9.38%
Close 11-09 16:00（ET）
120.26MMarket Cap
LossP/E TTM
Today
+9.38%
5 Days
+8.53%
1 Month
+52.17%
6 Months
+122.22%
Year to Date
+26.70%
1 Year
+45.83%
Key Figures
2.610Open
2.870High
72.03KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.17%Turnover Ratio
2.560Prev. Close
2.555Low
199.17KTurnover
LossP/E Static
3.51P/B
0.00%Div Yield TTM
-39.31%ROA
3.25052wk High
0.08Volume Ratio
-56.39MNet Profit
42.95MShares
-1.2916EPS TTM
0.27Beta
-86.22%ROE
1.13052wk Low
17.97%Amplitude
76.19%Gross Margin
120.26MMarket Cap
14.03Reward/Risk
6.24%Risk Rate
Pulmonx Corp's Score
0.13vs previous score
Forecast7.60
Financial Health6.55
Technical6.92
Valuation Dimensions7.80
Institutional Confidence7.00
Risk Assessment2.27
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Pulmonx Corp Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Pulmonx Corp Latest Earnings Call Transcripts
Pulmonx (LUNG) Q3 2026 Earnings Call: Revenue Returns to Growth
Pulmonx Q3 2026 revenue rose 6% to $22.8 million as adjusted EBITDA loss narrowed nearly 60%. Management reaffirmed $90 million-$92 million guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.19/-0.26
Revenue / Forecast
22.84M/21.94M
Pulmonx Corp Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolLUNG
Number of employees291
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| PRIMECAP Management Company | 11.19% |
| Morgan Stanley & Co. LLC | 9.21% |
| Soleus Capital Management, L.P. | 6.31% |
| BlackRock Institutional Trust Company, N.A. | 5.82% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 33.62% |
| Hedge Fund | 21.60% |
| Investment Advisor/Hedge Fund | 13.04% |
| Research Firm | 12.57% |
Related Instruments
+0.88%
+3.87%
+0.53%
+2.12%
+1.71%
+0.97%
-0.04%
+1.67%
+2.00%
-1.73%
+0.68%
+3.66%
+2.97%
+2.52%
+1.59%
+4.53%
+2.70%
-2.43%
+3.10%
+0.88%
FAQs
What is the current price of Pulmonx Corp (LUNG)?
The current price of Pulmonx Corp (LUNG) is 2.80.
What is the symbol of Pulmonx Corp?
The ticker symbol of Pulmonx Corp is LUNG.
What is the 52-week high of Pulmonx Corp?
The 52-week high of Pulmonx Corp is 3.25.
What is the 52-week low of Pulmonx Corp?
The 52-week low of Pulmonx Corp is 1.13.
What is the market capitalization of Pulmonx Corp?
The market capitalization of Pulmonx Corp is 120.26M.
Is Pulmonx Corp (LUNG) currently rated as Buy, Hold, or Sell?
According to analysts, Pulmonx Corp (LUNG) has an overall rating of Buy, with a price target of 3.62.
What is the Earnings Per Share (EPS TTM) of Pulmonx Corp (LUNG)?
The Earnings Per Share (EPS TTM) of Pulmonx Corp (LUNG) is -1.29.